EcoDrugPlus

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSFCAG00000002830
Gene Symbol: TEK
5 Cross references
166 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSFCAG00000027168
Gene Symbol: TTK
5 Cross references
205 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSFCAG00000031025
Gene Symbol: UGCG
5 Cross references
212 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSFCAG00000023566
Gene Symbol: WEE1
5 Cross references
227 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSFCAG00000009235
Gene Symbol: YES1
5 Cross references
260 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSFCAG00000023546
Gene Symbol: ACHE
5 Cross references
234 Possible Orthologues:

Activin A Receptor Like Type 1

Ensembl ID : ENSFCAG00000000265
Gene Symbol: ACVRL1
5 Cross references
358 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSFCAG00000003157
Gene Symbol: ACVR2B
5 Cross references
259 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSFCAG00000013109
Gene Symbol: ADORA1
5 Cross references
275 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSFCAG00000028685
Gene Symbol: ADORA2A
5 Cross references
264 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSFCAG00000029569
Gene Symbol: ADORA3
5 Cross references
273 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSFCAG00000002474
Gene Symbol: ADA
5 Cross references
219 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).